Thymagen (Thymogen)
Also known as Thymogen
Research Goal: Investigating the restoration of immune homeostasis and the stimulation of T-cell maturation in models of immunodeficiency.
Route
Subcutaneous injection
Dose range
100 mcg – 500 mcg
Frequency
Once daily
Cycle length
10 days; often repeated every 3–6 months
Overview
Research Goal: Investigating the restoration of immune homeostasis and the stimulation of T-cell maturation in models of immunodeficiency.
Preparation: Reconstitute with 2.0 mL sterile water or saline (Conc: 500 mcg/mL or 1 mg/mL).
Studied benefits
- A bioregulatory dipeptide (Glu-Trp) that supports the immune system
- It works by normalizing the function of T-lymphocytes and enhancing the body's response to infection and chronic inflammation
- It is often used to support recovery from illness or to bolster immune defense during aging
Reported side effects
- Extremely well-tolerated with an excellent safety record in Russian clinical trials
- Side effects are typically limited to minor, transient irritation at the injection site
Protocol
Dosing Schedule (Subcutaneous / Intramuscular)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Intensity | Daily Dose (mcg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Standard Protocol | 100 mcg | 4 units (0.04 mL) | + Log |
| Intensive Research | 500 mcg | 20 units (0.2 mL) | + Log |
Frequency
Once daily.
Timing
Consistent morning administration.
Cycle length
10 days; often repeated every 3–6 months.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
50 doses of 100 mcg per vial
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Maintain a diet rich in antioxidants and B-vitamins to support the immune system while this L-Glu-L-Trp dipeptide bioregulator targets the restoration of thymus function and T-cell differentiation. Stay physically active with moderate exercise to promote systemic circulation and lymphatic drainage, which facilitates the delivery of the peptide to target immune tissues. Ensure 7–9 hours of quality sleep to support the body’s natural nocturnal immune surveillance and cellular repair. Avoid chronic stress and environmental pollutants, as these factors can suppress thymic activity and counteract the peptide’s role in normalizing the immune response.
Evidence
Research summaries
Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 and Thymogen in Immunomodulation
Findings: Makes immune fighter cells stronger and safer, fixes weak defenses without side effects.
Doctors looked at many tests on people and found Thymogen safely boosts immune cells and germ-fighters. It helps sick people get better without causing problems, great for weak immune systems.
Read the study ↗The First Reciprocal Activities of Chiral Peptide Pharmaceuticals: Thymogen and Thymodepressin, as Examples
Findings: Turns up immune power when low, calms it when too high, keeps balance perfect.
Thymogen is smart—it helps when your defenses are weak but chills them out if they're too strong (like in allergies). This keeps your body from attacking itself.
Read the study ↗Peptide bioregulators: the new class of geroprotectors. Message 2: Introduction into clinical practice
Findings: Helps live healthier longer by keeping immune system young, fixes problems in diabetes.
Long tests on people showed Thymogen keeps immune fighters working well into old age. In diabetes patients, it fixed almost all immune weaknesses, helping fight sickness better. Thymagen is like a coach for your immune team, training fighters, boosting energy against germs, and keeping everything balanced for better health.
Read the study ↗Identification
Chemistry
- cas
- 38101-59-6
- formula
- C₁₆H₁₉N₃O₅
- molecular weight
- 333.34 Da (or 333.3 g/mol)
- sequence
- -
- source
- Synthetic; modeled after naturally occurring peptide complex originally extracted from calf thymus
- biosynthesis
- Chemically synthesized dipeptide via recombinant DNA techniques; nonribosomal origin
- type
- Linear dipeptide
Keep exploring
Related peptides
ARA-290
ARA290 · Cibinetide
- Route
- Subcutaneous
- Dose
- 4 mg – 8 mg
- Cycle
- 4–8 weeks
Bronchogen
AEDL · Ala-Glu-Asp-Leu peptide
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; often repeated every 4–6 months
Cardiogen
AEDR · Ala-Glu-Asp-Arg peptide
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days
Cartalax
AED · Ala-Glu-Asp
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days